PREVALENCE AND PREDICTIVE FACTORS ASSOCIATED WITH POSITIVITY OF SARS-COV-2 SEROLOGICAL MARKERS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AT AN IBD REFERRAL CENTER.

Sandro da Costa Ferreira Rogério Serafim Parra Marley Ribeiro Feitosa Omar FÉres Rodrigo de Carvalho Santana Luiz Ernesto de Almeida Troncon

Published in: Arquivos de gastroenterologia (2022)

SARS-CoV-2 previous infection in IBD patients was not that uncommon, and its prevalence was 11.2% in our series. Positivity to SARS-CoV-2 serological markers was associated with female sex, extra-intestinal manifestations, use of corticosteroids, and contact with individuals with suspected or confirmed COVID-19. Studies with longer follow-up periods are needed to confirm these findings.

Keyphrases

sars cov
respiratory syndrome coronavirus
patients with inflammatory bowel disease
end stage renal disease
risk factors
ejection fraction
newly diagnosed
chronic kidney disease
primary care
peritoneal dialysis
coronavirus disease
prognostic factors
pulmonary embolism
patient reported